Relationship between electrocortical activity and beta-adrenergic receptor function in the rat after chronic desimipramine treatment
- PMID: 2547025
- DOI: 10.1007/BF01247115
Relationship between electrocortical activity and beta-adrenergic receptor function in the rat after chronic desimipramine treatment
Abstract
The aim of this study was to investigate the effects of chronic administration of desimipramine (DMI) after 2, 7 or 20 mg/kg per day, administered by osmotic minipumps, on electrocortical activity and beta-adrenergic receptors in rat brain. Rats receiving DMI chronically show a dose- and time-dependent increase of electrocortical activity above 15 Hz as well as a dose- and time-dependent decrease below 15 Hz. Already after 3 days of treatment a clear effect on the electrocorticogram (ECoG) was seen. The maximal change in the ECoG was reached at the end of the study, after 24 days of treatment. After acute treatment (20 and 45 minutes after 2, 4 or 10 mg/kg i.p.) with DMI, a decrease of electrocortical activity is seen above 15 Hz. Thus the effect of acute DMI treatment on the ECoG is different from that of chronic treatment. In the same group of rats the effect of chronic DMI treatment on the beta-adrenergic receptor number was determined 24 hours after the last ECoG recording. The number of beta-adrenergic receptors was dose dependently reduced in the DMI-treated rats as determined by [3H]-dihydroalprenolol binding. There was no change in affinity (KD) of the ligand for the beta-receptor. This finding was corroborated by a decrease in the functional activity of the beta-adrenergic receptors, as determined by isoprenaline stimulated efflux of cyclic-AMP in cortex slices. These data indicate that chronic treatment with DMI, resulting in a down-regulation of the cortical beta-adrenergic system, is paralleled by pronounced effects on the ECoG of rats. The different ECoG profiles after chronic DMI treatment compared with acute treatment suggest that adaptive changes in the electrical brain activity continually develop during the chronic treatment with this antidepressant drug.
Similar articles
-
Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.Mol Pharmacol. 1989 Jul;36(1):211-8. Mol Pharmacol. 1989. PMID: 2546051
-
The significance of beta-adrenoceptor down regulation in the desipramine action in the forced swimming test.Naunyn Schmiedebergs Arch Pharmacol. 1986 May;333(1):31-5. doi: 10.1007/BF00569656. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2874504
-
5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.J Neurochem. 1994 Jun;62(6):2262-8. doi: 10.1046/j.1471-4159.1994.62062262.x. J Neurochem. 1994. PMID: 8189233
-
Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions.Neuropharmacology. 1983 Mar;22(3 Spec No):415-24. doi: 10.1016/0028-3908(83)90191-0. Neuropharmacology. 1983. PMID: 6304559 Review.
-
Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase.Ann N Y Acad Sci. 1984;430:91-101. doi: 10.1111/j.1749-6632.1984.tb14500.x. Ann N Y Acad Sci. 1984. PMID: 6331266 Review.